UMAC insider plans sale of 8,750 shares in Form 144 filing

UMAC filed a Form 144 notice indicating that shareholder Andrew Ross Camden may sell up to 8,750 shares of common stock through Maxim Group on the NYSE American, with an aggregate market value of $77,700.00.

Accepted by SEC EDGAR 11/20/2025 - 08:31 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

UMAC filed a Form 144 notice indicating that shareholder Andrew Ross Camden may sell up to 8,750 shares of common stock through Maxim Group on the NYSE American, with an aggregate market value of $77,700.00. The filing notes that 36,875,549 shares of common stock were outstanding.

Camden previously acquired 100,000 shares of common stock on 02/03/2025 via restricted stock units from the issuer as compensation, with a payment date of 11/20/2025. Over the past three months, he sold 8,750 shares for $85,468.00 on 08/20/2025 and 35,000 shares for $356,187.00 on 08/21/2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the UMAC Form 144 filing disclose?

The Form 144 for UMAC discloses that shareholder Andrew Ross Camden may sell up to 8,750 shares of UMAC common stock through Maxim Group on the NYSE American, with an aggregate market value of $77,700.00.

How many UMAC shares is the insider planning to sell under this Form 144?

The filing states that up to 8,750 shares of UMAC common stock are to be sold, with an aggregate market value of $77,700.00.

How many UMAC shares were outstanding according to the Form 144?

The Form 144 notes that there were 36,875,549 shares of UMAC common stock outstanding.

What UMAC stock sales has Andrew Ross Camden made in the past 3 months?

Over the past three months, Andrew Ross Camden sold 8,750 UMAC common shares for $85,468.00 on 08/20/2025 and 35,000 shares for $356,187.00 on 08/21/2025.

How did Andrew Ross Camden acquire his recent UMAC shares?

The filing shows that Camden acquired 100,000 UMAC common shares on 02/03/2025 via restricted stock units from the issuer as compensation, with a payment date of 11/20/2025.

Which broker is handling the planned UMAC share sale under Form 144?

The Form 144 lists Maxim Group, located at 300 Park Ave, 16th Floor, New York, NY 10022, as the broker for the planned sale of 8,750 UMAC common shares on the NYSE American.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002014748
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Unusual Machines, Inc.
SEC File Number	001-41961
Address of Issuer	4677 L B MCLEOD RD SUITE J ORLANDO FLORIDA 32811
Phone	720-383-8983
Name of Person for Whose Account the Securities are To Be Sold	Camden Andrew Ross
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Maxim Group 300 Park Ave 16th Floor New York NY 10022	8750	77700.00	36875549	11/20/2025	NYSE American

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/03/2025	Restricted Stock Units	Issuer			100000	11/20/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Andrew Ross Camden 4677 L B MCLEOD RD SUITE J ORLANDO FL 32811	Common Stock	08/20/2025	8750	85468.00
Andrew Ross Camden 4677 L B MCLEOD RD SUITE J ORLANDO FL 32811	Common Stock	08/21/2025	35000	356187.00

144: Remarks and Signature

Remarks
Date of Notice	11/20/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/16/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Dominick Iadicicco, as a duly authorized representative of Maxim Group LLC., as attorney-in-fact for Andrew Camden
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)